Topics and Expertise: type 2 diabetes

For the 37th consecutive year, the UCSF School of Pharmacy has received more funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States. School researchers were awarded $28.2 million in grants during NIH’s 2016 fiscal year, from October 1, 2015 to...

For the 36th consecutive year, the UCSF School of Pharmacy has received more funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

In people with type 2 diabetes, the body is less able to use the hormone insulin to regulate blood sugar. The disease affects 350 million patients globally—including 29 million in the United States, where it is the leading cause of blindness, kidney failure, and non-accident-related amputations.

The launch of a new community pharmacy-based diabetes medication management pilot program for select members of the California Public Employees’ Retirement System (CalPERS) was announced by CalPERS on July 15, 2010.